Similarity | Rank | |
---|---|---|
late-stage | 0.847 | 78840 |
high-growth | 0.748 | 62759 |
start-ups | 0.739 | 22618 |
biopharmaceutical | 0.721 | 64647 |
startups | 0.714 | 15635 |
biotech | 0.697 | 25117 |
pre-clinical | 0.685 | 79324 |
preclinical | 0.685 | 49806 |
start-up | 0.683 | 12119 |
cleantech | 0.682 | 63075 |
commercializing | 0.672 | 72928 |
low-risk | 0.671 | 42186 |
Genentech | 0.668 | 73045 |
high-risk | 0.665 | 18419 |
biomarker | 0.664 | 53333 |
technology-based | 0.660 | 59708 |
biologics | 0.656 | 70740 |
commercialization | 0.655 | 26074 |
therapeutics | 0.655 | 43727 |
commercialize | 0.650 | 51669 |
biotechnology | 0.645 | 20307 |
VCs | 0.641 | 50414 |
entrepreneurs | 0.641 | 5792 |
bioscience | 0.636 | 81746 |
proof-of-concept | 0.635 | 74320 |